Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mann

Showing results (591-600 of 622) with videos related to

Pageof 63
Sort By:
Molecular Cell|November 28, 2016
An RB-EZH2 Complex Mediates Silencing of Repetitive DNA SequencesCharles A Ishak, Aren E Marshall, Daniel T Passos, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2010
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptorMatthew D Vera, Joseph T Lundquist, Murty V Chengalvala, et al.
Bioorganic & Medicinal Chemistry|February 9, 2005
In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitorJin Li, Michael P Lynch, Kristin Lundy Demello, et al.
Journal of the American Board of Family Medicine : JABFM|September 9, 2011
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) studyNicolas A Forcade, Michael L Parchman, James H Jorgensen, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole templateDiane B Hauze, Murty V Chengalvala, Joshua E Cottom, et al.
Neurology. Genetics|January 18, 2024
Biallelic <i>SOX8</i> Variants Associated With Novel Syndrome With Myopathy, Skeletal Deformities, Intellectual Disability, and Ovarian DysfunctionJodi Warman-Chardon, Taila Hartley, Aren Elizabeth Marshall, et al.
Allergy|August 29, 1998
Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergensB R Balda, H Wolf, C Baumgarten, et al.
Journal of the American Board of Family Medicine : JABFM|September 6, 2013
Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) studyMatthew J Labreche, Grace C Lee, Russell T Attridge, et al.
Journal of Medicinal Chemistry|October 28, 2009
Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interactionJohn G Allen, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Journal of Medicinal Chemistry|March 11, 2009
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)Jeffrey C Pelletier, Murty V Chengalvala, Joshua E Cottom, et al.
Pageof 63

Showing results (591-600 of 622) with videos related to

Sort By:
Pageof 63
Molecular Cell|November 28, 2016
An RB-EZH2 Complex Mediates Silencing of Repetitive DNA SequencesCharles A Ishak, Aren E Marshall, Daniel T Passos, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2010
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptorMatthew D Vera, Joseph T Lundquist, Murty V Chengalvala, et al.
Bioorganic & Medicinal Chemistry|February 9, 2005
In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitorJin Li, Michael P Lynch, Kristin Lundy Demello, et al.
Journal of the American Board of Family Medicine : JABFM|September 9, 2011
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) studyNicolas A Forcade, Michael L Parchman, James H Jorgensen, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole templateDiane B Hauze, Murty V Chengalvala, Joshua E Cottom, et al.
Neurology. Genetics|January 18, 2024
Biallelic <i>SOX8</i> Variants Associated With Novel Syndrome With Myopathy, Skeletal Deformities, Intellectual Disability, and Ovarian DysfunctionJodi Warman-Chardon, Taila Hartley, Aren Elizabeth Marshall, et al.
Allergy|August 29, 1998
Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergensB R Balda, H Wolf, C Baumgarten, et al.
Journal of the American Board of Family Medicine : JABFM|September 6, 2013
Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) studyMatthew J Labreche, Grace C Lee, Russell T Attridge, et al.
Journal of Medicinal Chemistry|October 28, 2009
Discovery and optimization of chromenotriazolopyrimidines as potent inhibitors of the mouse double minute 2-tumor protein 53 protein-protein interactionJohn G Allen, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Journal of Medicinal Chemistry|March 11, 2009
Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R)Jeffrey C Pelletier, Murty V Chengalvala, Joshua E Cottom, et al.
Pageof 63